• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Amarin

Anonymous board for Amarin
Replies
19
Views
5K
anonymous
Replies
4
Views
326
anonymous
Replies
3
Views
484
anonymous
Replies
5
Views
2K
anonymous
Replies
14
Views
9K
anonymous
Replies
33
Views
10K
anonymous
Replies
3
Views
2K
anonymous
Replies
6
Views
2K
anonymous
Replies
12
Views
3K
anonymous
Replies
1
Views
1K
anonymous
Replies
14
Views
4K
anonymous
Replies
1
Views
2K
anonymous
Replies
2
Views
1K
anonymous
Replies
7
Views
2K
anonymous
Replies
6
Views
2K
anonymous
Replies
2
Views
815
anonymous
Replies
4
Views
3K
anonymous
Replies
4
Views
1K
anonymous
Replies
3
Views
2K
anonymous
Replies
2
Views
1K
anonymous